Gregory Klein

Gregory Klein is a highly experienced professional in the field of biomarker research and clinical imaging, currently serving as Head of Clinical Imaging for Neuroscience and Rare Diseases Biomarkers and Translational Technology at Roche since July 2020. Klein has held multiple roles at F. Hoffmann-La Roche Ltd. since August 2016, including Senior Principal Scientist and Principal Scientist. Prior experience includes leadership positions at BioClinica as Director of Molecular Imaging and at Synarc as Scientific Director and Senior Scientist. Klein's academic background includes a Ph.D. in Vision Science from the University of California, Berkeley, an MS in Electrical Engineering from the University of Maryland, and a BS in Electrical Engineering from the University of Nebraska-Lincoln.